$60.000
-0.222 (-0.37%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
XENE-Prognose durch Analyse ähnlicher Charts
Alphio's XENE stock price prediction model matches the current Xenon Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $61.98 (+3.30%). The 1-week path is $67.26 (+12.10%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Xenon Pharmaceuticals Inc-Aktien kaufen?
Xenon Pharmaceuticals is currently priced at $59.99, with a recent RSI of 38.054 indicating it is oversold. However, the company reported a significant net income loss of -$110.736 million in Q2 2026, which raises concerns about its financial health. While the stock has seen a year-to-date increase of +34.84%, the recent insider selling activity has surged by 904.19%, which could signal a lack of confidence among insiders. Given these factors, it may be prudent to hold off on buying until there are clearer signs of recovery and stability.
XENE schloss am Tuesday bei $60.00, nachdem der Kurs -0.37% fallen
Xenon Pharmaceuticals Inc (XENE) last closed at $60, losing -0.37%. These facts feed the 1-day and 1-week XENE price prediction above.
Analystenkonsens
Xenon Pharmaceuticals Inc (XENE): 3 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Xenon Pharmaceuticals Inc (XENE) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf XENE am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für XENE
Historically the probability of a positive September return for XENE is 2.38%. December offers the highest probability of a positive month at 51.16%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.